共 120 条
[1]
Mantegazza R(2003)Myasthenia gravis (MG): epidemiological data and prognostic factors Ann N Y Acad Sci 998 413-423
[2]
Baggi F(2001)Myasthenia gravis Lancet 357 2122-2128
[3]
Antozzi C(2010)History of outcome measures for myasthenia gravis Muscle Nerve 42 5-13
[4]
Confalonieri P(2014)Development of the MG-DIS: an ICF-based disability assessment instrument for myasthenia gravis Disabil Rehabil 36 546-555
[5]
Morandi L(2012)The myasthenia gravis—specific activities of daily living profile Ann N Y Acad Sci 1274 114-119
[6]
Bernasconi P(2011)MG-ADL: still a relevant outcome measure Muscle Nerve 44 727-731
[7]
Andreetta F(2016)Major motor-functional determinants associated with poor self-reported health-related quality of life in myasthenia gravis patients Neurol Sci 37 717-723
[8]
Simoncini O(2016)Randomized trial of thymectomy in myasthenia gravis N Engl J Med 375 511-522
[9]
Campanella A(2008)An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis Neurology 71 400-406
[10]
Beghi E(2016)Validation of the Besta Neurological Institute rating scale for myasthenia gravis Muscle Nerve 53 32-37